A part of the Hybrid Closed-Loop Outpatient Trial will examine if an artificial pancreas can be used to treat hypoglycaemia (low blood sugar) unawareness.
This occurs when the body cannot detect dangerously low blood sugar levels and can affect one in five people living with type 1 diabetes.
Study lead Dr Marie-Anne Burckhardt, from Princess Margaret Hospital, said researchers were hoping to recruit people aged 12 to 55 years who were already on an insulin pump and who have difficulty detecting when they were having a hypo.
“We already know that by avoiding hypos for several weeks we can improve hypoglycaemic awareness but this often means running the blood glucose levels quite high for a while,” Dr Burckhardt said.
“We want to test the use of a hybrid closed-loop insulin delivery system, which has been shown to cause less hypos but without running blood glucose levels high and see if the awareness improves.”
For more information, contact Dr Burckhardt on 6229 3317 or Marie-Anne.Burckhardt@health.wa.gov.au
Donate to Diabetes WA to help us raise awareness about type 1 and type 2 diabetes in your local area!